| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Feng Chen | |
| Yicheng Ni | |||
| Binghu Jiang | |||
| Jichen Wang | |||
| P2860 | cites work | Porphyrins as theranostic agents from prehistoric to modern times | Q28716876 |
| Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin | Q31024093 | ||
| Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells | Q31102622 | ||
| Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis | Q32171787 | ||
| Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer | Q33372304 | ||
| Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin | Q33875063 | ||
| Hypericin in cancer treatment: more light on the way. | Q34535031 | ||
| Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules | Q34567460 | ||
| Antimicrobial activity of seven hypericum entities from central Italy | Q34630361 | ||
| Non-invasive in vivo imaging of myocardial apoptosis and necrosis | Q35085602 | ||
| Transbilayer phospholipids molecular imaging. | Q35650805 | ||
| Necrosis avid contrast agents: functional similarity versus structural diversity | Q36198033 | ||
| Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models | Q36383717 | ||
| Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis | Q36389505 | ||
| Elucidation of the tumoritropic principle of hypericin. | Q36616701 | ||
| Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts | Q36619078 | ||
| Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy | Q37230322 | ||
| Molecular imaging of cell death | Q37441796 | ||
| Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy | Q39424696 | ||
| Selective enrichment of hypericin in malignant glioma: pioneering in vivo results | Q39576866 | ||
| High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL. | Q40028585 | ||
| Exploration of the mechanism underlying the tumor necrosis avidity of hypericin | Q40111582 | ||
| Photodynamic therapy in oncology: mechanisms and clinical use. | Q40882340 | ||
| Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. | Q41699202 | ||
| A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors | Q41740993 | ||
| Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice | Q41833814 | ||
| Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study | Q42523363 | ||
| A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis | Q42871258 | ||
| Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice | Q43675386 | ||
| MR contrast media for cardiovascular imaging | Q44052742 | ||
| Exploring multifunctional features of necrosis avid contrast agents | Q44109436 | ||
| Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy | Q44179287 | ||
| Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin | Q44191740 | ||
| The best of nuclear cardiology and MRI in 2002 | Q44338339 | ||
| Lipid-mediated preferential localization of hypericin in lipid membranes. | Q46051309 | ||
| 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe | Q46480033 | ||
| Accumulation and interaction of hypericin in low-density lipoprotein--a photophysical study | Q46627870 | ||
| Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy | Q46682915 | ||
| Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model. | Q46689675 | ||
| Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT. | Q46835357 | ||
| Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. | Q46851266 | ||
| First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent | Q46921929 | ||
| Selective enhancement of experimental rat brain tumors with Gd-TPPS. | Q48130679 | ||
| Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors | Q48218849 | ||
| Subcellular distributions and excited-state processes of hypericin in neurons | Q48256204 | ||
| Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy | Q48323161 | ||
| Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors | Q48445915 | ||
| Hypericin as an inactivator of infectious viruses in blood components | Q49228227 | ||
| Myocardial infarct quantification in the dog by single photon emission computed tomography. | Q50950452 | ||
| Comparison between nonspecific and necrosis-avid gadolinium contrast agents in vascular disrupting agent-induced necrosis of rodent tumors at 3.0T. | Q51568154 | ||
| A dual-targeting anticancer approach: soil and seed principle. | Q52613091 | ||
| Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results. | Q52973659 | ||
| Magnetic resonance imaging, microangiography, and histology in a rat model of primary liver cancer | Q53487877 | ||
| Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model. | Q53504747 | ||
| Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent. | Q53555220 | ||
| Visualization of stroke with clinical MR imagers in rats: a feasibility study. | Q53606653 | ||
| Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. | Q53994748 | ||
| Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential | Q56992887 | ||
| Evaluation of tumor affinity of mono-[123I]iodohypericin and mono-[123I]iodoprotohypericin in a mouse model with a RIF-1 tumor | Q56993103 | ||
| Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model | Q57188780 | ||
| Detection and Quantification of Breast Tumor Necrosis with MR Imaging | Q59401551 | ||
| Gadolinium Mesoporphyrin as an MR Imaging Contrast Agent in the Evaluation of Tumors | Q61737118 | ||
| Spectroscopic characterization and photobleaching kinetics of hypericin-N-methyl pyrrolidone formulations | Q63247461 | ||
| The distribution of various water soluble radioactive metalloporphyrins in tumor bearing mice | Q67322652 | ||
| Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody | Q70145897 | ||
| Tetra-p-aminophenylporphyrin conjugated with Gd-DTPA: tumor-specific contrast agent for MR imaging | Q70548436 | ||
| Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts | Q71510982 | ||
| MRI contrast enhancement of necrosis by MP-2269 and gadophrin-2 in a rat model of liver infarction | Q73554653 | ||
| Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings | Q74007464 | ||
| Mechanism of gadophrin-2 accumulation in tumor necrosis | Q74604734 | ||
| Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent | Q80345855 | ||
| Differentiation of residual tumor from benign periablational tissues after radiofrequency ablation: the role of MR imaging contrast agents | Q81391611 | ||
| Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer | Q81448546 | ||
| Kinetics of hypericin association with low-density lipoproteins | Q82652212 | ||
| On the mechanism of Candida spp. photoinactivation by hypericin | Q84080296 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 9 | |
| P921 | main subject | hydrocarbon | Q43648 |
| polycyclic compound | Q426145 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 667-676 | |
| P577 | publication date | 2013-08-10 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging | |
| P478 | volume | 3 |
| Q51734667 | Avenues to molecular imaging of dying cells: Focus on cancer. |
| Q36583834 | Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium |
| Q38818263 | Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones |
| Q39104569 | Fluorescent natural products as probes and tracers in biology. |
| Q36569572 | Illuminating necrosis: From mechanistic exploration to preclinical application using fluorescence molecular imaging with indocyanine green. |
| Q37588304 | Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy |
| Q30388052 | Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models |
| Q37389690 | Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging |
| Q30370566 | The Necrosis-Avid Small Molecule HQ4-DTPA as a Multimodal Imaging Agent for Monitoring Radiation Therapy-Induced Tumor Cell Death. |
Search more.